Several novel therapies for castration-resistant prostate cancer (CRPC) have been approved with randomized phase III studies with continuing observational research either planned or ongoing.

Cardiovascular health Researchers sought to determine CV event occurrence in patients treated with immune checkpoint inhibitors and assess the accuracy of diagnosis by ICD code compared with ...

Regard has upgraded its AI platform to enable doctors to more accurately diagnose patients at the bedside. The company developed a proprietary diagnostic engine to identify missed conditions like ...

Please provide your email address to receive an email when new articles are posted on . Nearly half of patients who received a diagnosis code of “unspecified mycosis” had positive laboratory test ...